Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

1, 4-benzodioxan-substituted Thienyl chalcone derivatives as novel reversible inhibitors of human monoamine oxidase B with anti-neuroinflammatory activity
Demeng Sun, Mengxue Mu, Yanmei Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B
L.G. Iacovino, Luca Pinzi, Giorgio Facchetti, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 7, pp. 1151-1158
Open Access | Times Cited: 24
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
Jiseong Lee, Saranya Kattil Parmbil, Nagendar Kumar Pandit, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Development of 5-phenylnitro bearing furan-based chalcones as a new class of potent MAO-B inhibitors
Kadeeja Thottungal Kalathil, Bishnu Prasad Pandey, Arshida Thottile Peedikayil, et al.
Future Medicinal Chemistry (2025), pp. 1-9
Closed Access
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
Mehmet Abdullah Alagöz, Jong‐Min Oh, Yaren Nur Zenni, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3801-3801
Open Access | Times Cited: 16
Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry
Bijo Mathew, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2022) Vol. 7, Iss. 9, pp. 8184-8197
Open Access | Times Cited: 15
Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors
Bijo Mathew, Ravichandran Veerasamy, Seenivasan Raghuraman, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9256-9266
Closed Access | Times Cited: 15
Chalcones bearing nitrogen‐containing heterocyclics as multi‐targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Yusuf Sıcak, Hüseyin Kekeçmuhammed, Ayşegül Karaküçük‐İyidoğan, et al.
Journal of Molecular Recognition (2023) Vol. 36, Iss. 7
Closed Access | Times Cited: 8
Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8
Design, synthesis of novel peripherally tetra-chalcone substituted phthalocyanines and their inhibitory effects on acetylcholinesterase and carbonic anhydrases (hCA I and II)
Tayfun Arslan
Journal of Organometallic Chemistry (2021) Vol. 951, pp. 122021-122021
Closed Access | Times Cited: 20
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1152-1152
Open Access | Times Cited: 14
Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson's disease
Chao Yi, Xinchang Liu, Kangzhi Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115308-115308
Closed Access | Times Cited: 7
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study
Della Grace Thomas Parambi, Jong‐Min Oh, Sunil Kumar, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107899-107899
Closed Access | Times Cited: 7
Chalcones As Broad‐Spectrum Antimicrobial Agents: A Comprehensive Review And Analysis Of Their Antimicrobial Activities
Tariq Nawaz, Affifa Tajammal, Aisha Waheed Qurashi
ChemistrySelect (2023) Vol. 8, Iss. 45
Closed Access | Times Cited: 7
Selected 1,3‐Benzodioxine‐Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors
Geum Seok Jeong, Swafvan Kaipakasseri, Sang Ryong Lee, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2257-2263
Closed Access | Times Cited: 19
Current Progress in Quinazoline Derivatives as Acetylcholinesterase and Monoamine Oxidase Inhibitors
Nisha Abdul Rehuman, Abdullah G. Al‐Sehemi, Della Grace Thomas Parambi, et al.
ChemistrySelect (2021) Vol. 6, Iss. 28, pp. 7162-7182
Closed Access | Times Cited: 16
Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment
Yangjing Lv, Miaoliang Fan, Jiayan He, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116566-116566
Closed Access | Times Cited: 2
Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones
Reshma Susan Ipe, Jong‐Min Oh, Sunil Kumar, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones
Ashutosh Kumar Singh, Seong‐Min Kim, Jong‐Min Oh, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 271-284
Open Access | Times Cited: 6
Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections
Francesca Arrighi, Arianna Granese, Paola Chimenti, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 3, pp. 211-245
Closed Access | Times Cited: 6
Development of a New Class of Monoamine Oxidase-B Inhibitors by Fine-Tuning the Halogens on the Acylhydrazones
Jayalakshmi Jayan, Jiseong Lee, Sunil Kumar, et al.
ACS Omega (2023) Vol. 8, Iss. 50, pp. 47606-47615
Open Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
Muhammed Çeçen, Jong‐Min Oh, Zeynep Özdemir, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5371-5371
Open Access | Times Cited: 15
Herbal glycosides in healthcare
Benito Soto‐Blanco
Elsevier eBooks (2021), pp. 239-282
Closed Access | Times Cited: 14
Ameliorative effect of ethoxylated chalcone-based MAO-B inhibitor on behavioural predictors of haloperidol-induced Parkinsonism in mice: evidence of its antioxidative role against Parkinson’s diseases
Naseer Maliyakkal, Uzma Saleem, Fareeha Anwar, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 5, pp. 7271-7282
Closed Access | Times Cited: 13
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies
Mariangela Agamennone, Marialuigia Fantacuzzi, Simone Carradori, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7884-7884
Open Access | Times Cited: 9

Scroll to top